Oral delivery of chitosan-coated PLGA nanoemulsion loaded with artesunate alleviates ulcerative colitis in mice.

[1]  R. Bo,et al.  The protective effect and potential mechanisms of eugenol against Salmonella in vivo and in vitro , 2022, Poultry science.

[2]  S. T. Olalla Saad,et al.  Artesunate strongly modulates myeloid and regulatory T cells to prevent LPS-induced systemic inflammation. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Michael J. Steinbaugh,et al.  Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans , 2020, Cell.

[4]  Zhongjiang Wang,et al.  Protective Effect of Iridoid Glycosides of the Leaves of Syringa oblata Lindl. on Dextran Sulfate Sodium-Induced Ulcerative Colitis by Inhibition of the TLR2/4/MyD88/NF-κB Signaling Pathway , 2020, BioMed research international.

[5]  Xiguang Chen,et al.  Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review. , 2020, International journal of biological macromolecules.

[6]  G. Cabrera-Barjas,et al.  Chilean crab (Aegla cholchol) as a new source of chitin and chitosan with antifungal properties against Candida spp. , 2020, International journal of biological macromolecules.

[7]  Haifeng Yang,et al.  Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response , 2020, Inflammation.

[8]  Y. Zhuang,et al.  Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon , 2019, BMC Cancer.

[9]  Baojian Wu,et al.  REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis , 2018, Nature Communications.

[10]  Chi-Ming Liu,et al.  The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway , 2018, International journal of molecular sciences.

[11]  M. Neurath,et al.  Current and emerging therapeutic targets for IBD , 2017, Nature Reviews Gastroenterology & Hepatology.

[12]  A. Trapani,et al.  Mucoadhesive properties of low molecular weight chitosan‐ or glycol chitosan‐ and corresponding thiomer‐coated poly(isobutylcyanoacrylate) core‐shell nanoparticles , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  M. L. Lia Fook,et al.  Preparation and Characterization of Chitosan Obtained from Shells of Shrimp (Litopenaeus vannamei Boone) , 2017, Marine drugs.

[14]  Lifei Hou,et al.  Immune suppressive properties of artemisinin family drugs. , 2016, Pharmacology & therapeutics.

[15]  P. Moseley,et al.  Intestinal epithelial barrier function and tight junction proteins with heat and exercise. , 2016, Journal of applied physiology.

[16]  Junhui Liu,et al.  Systemic delivery to central nervous system by engineered PLGA nanoparticles. , 2016, American journal of translational research.

[17]  C. Fiocchi,et al.  Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.

[18]  F. Nepveu,et al.  Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities. , 2015, International journal of pharmaceutics.

[19]  R. Russell,et al.  Management of ulcerative colitis , 2015, Archives of Disease in Childhood.

[20]  G. Rogler,et al.  Extraintestinal Manifestations of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[21]  R. Aminov,et al.  Differential induction of total IgE by two Salmonella enterica serotypes , 2015, Front. Cell. Infect. Microbiol..

[22]  Lifei Hou,et al.  Anti-Inflammatory and Immunoregulatory Functions of Artemisinin and Its Derivatives , 2015, Mediators of inflammation.

[23]  H. Jagani,et al.  Strategies for drug delivery to the central nervous system by systemic route , 2015, Drug delivery.

[24]  O. Nielsen.  New Strategies for Treatment of Inflammatory Bowel Disease , 2014, Front. Med..

[25]  S. Hasnain,et al.  IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. , 2013, Gastroenterology.

[26]  Yue-Wern Huang,et al.  Protein transduction in human cells is enhanced by cell-penetrating peptides fused with an endosomolytic HA2 sequence , 2012, Peptides.

[27]  P. Pantazis,et al.  Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency. , 2012, Methods in molecular biology.

[28]  G. Storm,et al.  Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. , 2012, ALTEX.

[29]  R. Dubey,et al.  Development and characterization of colon specific drug delivery system bearing 5-ASA and camylofine dihydrochloride for the treatment of ulcerative colitis , 2010, Journal of drug targeting.

[30]  A. Lamprecht.  IBD: Selective nanoparticle adhesion can enhance colitis therapy , 2010, Nature Reviews Gastroenterology &Hepatology.

[31]  M. Boivin,et al.  Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.

[32]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[33]  S. Kosaraju.  Colon Targeted Delivery Systems: Review of Polysaccharides for Encapsulation and Delivery , 2005, Critical reviews in food science and nutrition.

[34]  Hans P Merkle,et al.  Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. , 2005, Journal of Controlled Release.

[35]  G. Smagghe,et al.  Fungicidal effect of chitosan derivatives containing an N-alkyl group on grey mould Botryti77s cinerea and rice leaf blast Pyricularia grisea. , 2005, Communications in agricultural and applied biological sciences.

[36]  Elisabetta Dejana,et al.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.

[37]  Abul Kalam Azad,et al.  Chitosan membrane as a wound-healing dressing: characterization and clinical application. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[38]  Jayanth Panyam,et al.  Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. , 2003, International journal of pharmaceutics.

[39]  C. Figdor,et al.  Towards a molecular understanding of dendritic cell immunobiology. , 2000, Immunology today.

[40]  P Buri,et al.  Chitosan: a unique polysaccharide for drug delivery. , 1998, Drug development and industrial pharmacy.